Access and Utilization of New Antidepressant and Antipsychotic Medications. Comparison of Psychotherapeutic Utilization with Utilization of Other Drug Classes


New-generation antidepressants and antipsychotics have been accepted into common use by Medicaid programs at about the same rate and to the same extent as other innovator drugs.

  • Newer antipsychotics appear to be proportionally more expensive than other new generation pharmaceuticals such as oral antidiabetics. Newer antidepressants appear to be roughly equivalent in cost to these other classes.